Delivery Order 36C24821D0103-36C24821N1094

Award Date 9/29/21
Potential Completion Date 9/29/22
Potential Value $1.5M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price purchase order was awarded by the Department of Veterans Affairs Veterans Health Administration to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments, to provide an NGS (Next Generation Sequencing) platform. The $162,825 contract has a completion date of September 30, 2021 and does not include any set-aside designation. Through previous prime federal contract awards, Illumina has supplied a range of its sequencing platforms, reagents,...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The contract, valued at $497,245.96, is for the provision of Illumina's genomic sequencing services and related products, including sequencing instruments like NextSeq, NovaSeq, and MiSeq systems, along with associated reagents, consumables, maintenance, and technical support. The contract does not...
This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The $164,980.62 contract provides reagents to support whole genome sequencing using Illumina's MiSeq and NextSeq 2000 platforms, with a performance period through December 2023. The contract has no set-aside designation. Illumina is a well-established provider of sequencing solutions to federal agencies, having received...
This is a $33,773.36 firm fixed-price delivery order awarded by the Department of Veterans Affairs (VA) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The order is for the purchase of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, along with associated reagents and kits. This delivery order was not set aside for any small business categories. Illumina has previously provided sequencing goods and services to support research and diagnostics...
This firm fixed-price delivery order was awarded by the Northeast Area Division of a civilian federal agency to Illumina, Inc., a leading provider of genetic sequencing technologies and services. The $24,752.43 contract is for the purchase of supplies used to operate Illumina's sequencing instruments, which will be used to sequence DNA samples. The contract has a period of performance through May 2025 and does not utilize any set-aside designations. Illumina holds multiple Indefinite Delivery...
This is a firm fixed price delivery order awarded by the National Institutes of Health (NIH) Clinical Center to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $15,807.96 award provides Illumina's proprietary sequencing systems, reagents, and services to support nucleic acid sequencing needs, with no set-aside designation. The order is part of a larger Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery, valued up...
This is a firm fixed-price delivery order awarded by a civilian federal agency to Illumina, Inc., a leading manufacturer and provider of genetic sequencing and genomic analysis technologies. The contract is for the procurement of NextSeq 500/550 High Output Kits, with a ceiling value of $167,409.46 and a performance period through May 2025. The award does not utilize any set-aside designations. Illumina holds multiple indefinite delivery vehicle (IDV) contracts with the Department of Veterans...
This firm fixed-price purchase order was awarded by the Department of the Navy Bureau of Medicine and Surgery to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $116,503.92 contract is for the delivery of undisclosed sequencing products and services to support the agency's mission. Illumina has an Indefinite Delivery Contract worth up to $3.3 million with the Navy for providing reagents and controls for various Illumina sequencing platforms used by the Naval...
This is a firm fixed price delivery order awarded by the Office of Administrative Services Procurement Management Branch, a civilian agency, to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The $98,056.80 order is for Illumina kits with no set-aside designation. Illumina has a history of providing sequencing systems and consumables to support genomic research and diagnostics across various federal agencies including NIH, CDC, USDA, and VA. This...
The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed price delivery order contract worth $344,084.80 to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. This order is not part of a set-aside program. Illumina will provide microarray kits to support genomic sequencing and analysis for research and diagnostics purposes at the agency. Illumina has previously provided a range of sequencing instruments,...
  • 36C24821D0103
    Indefinite Delivery Contract
  • 36C24821D0103-36C24821N1094
    Delivery Order

This is a firm fixed price delivery order contract awarded by the Department of Veterans Affairs Veterans Health Administration to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $1,511,777.82 contract is for Next Generation Sequencing laboratory services to be performed in San Diego, CA. Illumina has previously provided sequencing systems, reagents, and services to support research and diagnostic initiatives at various federal agencies. While there is no set-aside designation, Illumina's proprietary sequencing technology and sole source status have resulted in prior delivery orders for supplies and maintenance services. This award appears to leverage Illumina's existing Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery for nucleic acid sequencing capabilities.

Generated 5/1/24, 10:03 AM